Losing Vision From CMV Retinitis? Why Foscavir Remains a Key Option for Resistant Cases
Vision changes can be frightening, especially when they happen quickly or during an already difficult health journey. For patients and caregivers dealing with cytomegalovirus (CMV) retinitis, understanding why a particular treatment may be discussed can make complex conversations feel a little easier to navigate. This guide looks at Foscavir and the questions patients may want to explore with their healthcare team when discussing treatment options for CMV retinitis.
Why CMV Retinitis Can Be a Serious Eye Emergency
Cytomegalovirus retinitis (CMVR) is a serious eye infection that requires prompt medical attention. It can be serious because it may progress and cause permanent vision loss if left untreated. Early diagnosis and treatment can help control the infection and reduce the risk of further damage to the retina.
CMV retinitis usually starts in the outer part of the retina and can spread to other areas of the eye over time. If it is not treated promptly, it may lead to serious complications such as retinal detachment, which can cause vision loss. If you notice new vision changes, such as blurred vision, floaters, or blind spots, it's important to contact your eye specialist as soon as possible.1
What Is CMV Retinitis?
Cytomegalovirus (CMV) retinitis is an eye infection caused by the cytomegalovirus (CMV). After a person is infected, the virus can remain inactive in the body for many years without causing any problems. However, if the immune system becomes severely weakened, the virus may become active again and affect different parts of the body, including the eyes.1
CMV retinitis is one of the most common CMV-related eye infections in people with weakened immune systems. It affects the retina, the light-sensitive layer at the back of the eye that helps you see. Without prompt treatment, the infection can damage the retina and lead to vision problems.1
Symptoms may develop gradually or suddenly and can include1
- Blurred vision
- Floaters (small moving spots that drift across your vision)
- Flashing lights
- Blind spots
Who Is More at Risk of CMV Retinitis?
CMV retinitis most often affects people whose immune system is severely weakened. This includes people living with advanced HIV infection, especially those with very low CD4 cell counts (a type of white blood cell that helps the body fight infections). It can also occur in some people who have received an organ transplant or are taking medicines that weaken the immune system to treat certain medical conditions.1,2
CMV retinitis may not cause noticeable symptoms in its early stages. For people at higher risk, regular eye examinations can help detect the infection early, allowing treatment to begin before significant damage to vision occurs.1
How CMV Retinitis Can Affect Vision
CMV retinitis can affect vision in different ways depending on which part of the retina is involved. Some people notice symptoms gradually, while others experience sudden changes in their eyesight. 1
Common symptoms include:
- Blurred vision
- Floaters (small moving spots in your vision)
- Flashes of light
- Blind spots
Without prompt treatment, the infection can continue to damage the retina. In some cases, it may lead to retinal detachment, where the retina pulls away from the back of the eye. This is a serious complication that requires urgent medical attention and may result in permanent vision loss if not treated promptly.1
Early diagnosis and treatment can help control the infection, reduce further damage to the retina, and preserve as much vision as possible.1
What Is Foscavir?
Foscavir® (foscarnet sodium) is an antiviral medicine that may be used to treat CMV retinitis in certain people with weakened immune systems. It works by stopping the virus from making copies of itself, helping to control the infection and reduce further damage to the retina.3
Doctors may consider Foscavir when other antiviral medicines are not suitable, have not worked well, or when the virus has become resistant to treatment. The decision to use Foscavir depends on your individual medical condition, previous treatments, and your healthcare team's assessment.
When Doctors May Consider Foscavir for CMV Retinitis
The choice of treatment for CMV retinitis depends on several factors, including the severity of the infection, the patient's overall health, previous antiviral treatments, and how well the virus is responding to therapy. Your healthcare team will carefully assess your individual situation before recommending a treatment plan.1
Foscavir® (foscarnet sodium) may be considered for certain patients with CMV retinitis, particularly when other antiviral medicines are not suitable or when the virus is no longer responding to previous treatment because of antiviral resistance.3 Treatment decisions are always individualized, and not every patient with CMV retinitis will require Foscavir.
Your doctor may also consider factors such as kidney function, other medical conditions, and any medicines you are currently taking before deciding whether Foscavir is an appropriate treatment option.3
Foscavir in Resistant or Relapsed Viral Infection Cases
Sometimes, CMV may become resistant to antiviral medicines. This means that the virus changes in a way that makes certain treatments less effective. In other cases, the infection may relapse, meaning it returns after it had previously improved.4
Because Foscavir works differently from some other antiviral medicines, it may be used in certain resistant or relapsed CMV infections when considered appropriate by a specialist.3 However, the decision to use Foscavir depends on the individual patient, the results of clinical assessment, and current treatment guidelines.
It is important to remember that every person's response to treatment is different. Your healthcare team will monitor how well the medicine is working and make changes to your treatment plan if needed.
How Foscavir Treatment Is Usually Given and Monitored
Unlike some antiviral medicines that are taken by mouth, Foscavir is given as an intravenous (IV) infusion, meaning it is delivered slowly into a vein through a drip. Depending on your condition and your doctor's recommendation, treatment may be given in a hospital, infusion centre, or another healthcare setting where you can be closely monitored.3
Before treatment begins, your healthcare team will carry out blood tests to check your kidney function and measure important minerals in your blood, such as calcium, magnesium, potassium, and phosphate. These tests help ensure that Foscavir can be given as safely as possible.3
During treatment, you may receive extra fluids through your IV before or during the infusion. Staying well hydrated is an important part of treatment because it helps reduce the risk of kidney-related side effects associated with Foscavir.3
Regular follow-up appointments are also important. These visits allow your healthcare team to monitor your response to treatment, repeat blood tests when needed, and check for any side effects that may require adjustments to your care.
Kidney Function, Electrolytes and Other Safety Checks
Like all medicines, Foscavir can cause side effects. One of the most important is its potential effect on the kidneys. For this reason, your doctor will check your kidney function before and during treatment and may adjust the dose if necessary.3
Foscavir can also affect the levels of certain electrolytes—minerals in your blood such as calcium, magnesium, potassium, and phosphate that help your nerves, muscles, and heart function properly. Changes in these levels can sometimes cause symptoms such as muscle cramps, tingling or weakness.3
Your healthcare team will monitor these blood tests regularly throughout treatment. Let your doctor know if you notice any new or unusual symptoms while receiving Foscavir, even if they seem mild.
When to Seek Urgent Medical Help for Vision Changes
Patients should promptly contact their healthcare team if they notice new or worsening blurred vision, floaters, flashes of light, or blind spots.1
These symptoms do not always mean CMV retinitis is getting worse, but they should be assessed promptly. Early medical attention can help identify the cause and allow treatment to begin or be adjusted if needed.
Even if your symptoms improve, continue attending all scheduled follow-up appointments so your healthcare team can monitor your eye health and response to treatment.
How Rx4u May Support Access Through Named Patient Program Guidance
For patients prescribed Foscavir, accessing treatment may involve specific administrative, documentation, and import-related steps. Rx4U may help patients and caregivers navigate the Named Patient Program (NPP) process where applicable.
Rx4u provides information and guidance about these access pathways for patients and healthcare professionals. However, the availability of a Named Patient Program depends on country-specific regulations, product availability, and a doctor's clinical judgment. It does not guarantee access to treatment.5
If you have questions about accessing a medicine, speak with your treating specialist. They can advise whether any access programs may be appropriate in your individual situation.
Conclusion: Treating CMV Retinitis Requires Fast Specialist Care
CMV retinitis is a serious eye infection, but early diagnosis and prompt treatment can help protect your vision.1 For some patients, Foscavir® (foscarnet sodium) may be considered when other antiviral medicines are not suitable or when the virus has become resistant to previous treatment.3 Your healthcare team will recommend the most appropriate treatment based on your individual needs. If you notice any new or worsening vision changes, seek medical attention promptly and continue attending your follow-up appointments.
Medical Disclaimer:
This information is provided for educational purposes only and is not a substitute for professional medical advice. Medicine should only be taken under the guidance of a qualified healthcare provider. Patients should always consult their doctor for advice on diagnosis, treatment, and medication use, and should not make changes to their prescribed therapy without medical supervision.
References
- Zhang J, Kamoi K, Zong Y, et al. Cytomegalovirus Retinitis: Clinical Manifestations, Diagnosis and Treatment. Viruses. 2024;16(9):1427. Published 2024 Sep 7. doi:10.3390/v16091427
- Munro M, Yadavalli T, Fonteh C, Arfeen S, Lobo-Chan AM. Cytomegalovirus Retinitis in HIV and Non-HIV Individuals. Microorganisms. 2019;8(1):55. Published 2019 Dec 28. doi:10.3390/microorganisms8010055
- U.S. Food and Drug Administration. Foscavir (foscarnet sodium) injection prescribing information. 2020. Accessed July 10, 2026. Foscavir Prescribing Information
- Voigt S. Cytomegalovirus in haematopoietic cell transplantation: The troll is still there. Best Pract Res Clin Haematol. 2024;37(3):101565. doi:10.1016/j.beha.2024.101565.
- Patil S. Early access programs: benefits, challenges, and key considerations for successful implementation. Perspect Clin Res. 2016;7(1):4-8. doi:10.4103/2229-3485.173779
